GLP-1 Obesity Drugs Show Promise for Brain Disorders
Compounds inspired by weight-loss drugs are being trialled for schizophrenia, Parkinson’s disease, addiction and depression.
The story so far
2 publishers have covered this in 2 articles since 13 Oct 2026. Nature published first, on 13 October at 00:00 UTC; STAT followed 35h 54m later. The most recent article, from STAT, appeared on 14 October at 11:53 UTC.
Outlets reporting it: Nature (major outlet), STAT.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.